ACC CardiaCast: Mechanisms of Action of GLP-1 RAs and SGLT2 in the Care of Patients With Type 2 Diabetes and CVD
In this episode, Christopher Granger and Robert Eckel discuss how to improve the care of patients with type 2 diabetes and cardiovascular disease, including using antihyperglycemic drugs that have relatively recently been shown to have an important effect on reducing cardiovascular outcomes. Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.
